文献速递脑血管病

血管内卒中治疗后症状性颅内出血:预测模型的外部验证

Symptomatic Intracranial Hemorrhage After Endovascular Stroke Treatment: External Validation of Prediction Models.
PubMed 文献 · Stroke · 2023-01-23

该研究系统检索了预测再灌注治疗后症状性颅内出血(sICH)或颅内出血(ICH)的模型,并在MR CLEAN注册研究中外部验证。共纳入39项研究描述40个模型,最常用预测因子为基线NIHSS、年龄和血糖。在MR CLEAN注册研究(n=3180)中,sICH发生率为188/3180(5.9%)。模型区分度范围从0.51(SPAN-100)到0.61(SITS-SICH和STARTING-SICH),校准最佳的模型为IST-3、SITS-SICH和STARTING-SICH。结论认为这些模型在日常临床实践中区分度差,对该患者群体无临床实用性。

要点

  • 最常用预测因子为基线NIHSS(n=35)、年龄(n=22)和血糖水平(n=22)。
  • MR CLEAN注册研究中sICH发生率为188/3180(5.9%)。
  • 模型区分度范围0.51(SPAN-100)至0.61(SITS-SICH和STARTING-SICH),均低于0.7。

核心结论

  • 研究的预测sICH或ICH模型在血管内治疗后的日常临床实践中区分度差,因此对该患者群体无临床实用性。

研究设计与样本

  • 系统检索已开发或验证的预测再灌注治疗(静脉溶栓和/或血管内治疗)后sICH或ICH的模型,并在MR CLEAN注册研究(n=3180;荷兰急性缺血性卒中血管内治疗多中心随机临床试验)中进行外部验证。
  • 主要结局为根据海德堡出血分类定义的sICH。
  • 模型性能通过区分度(c-statistic,理想值为1;低于0.7认为区分度差)和校准(斜率,理想值为1;截距,理想值为0)评估。

主要发现

  • 共纳入39项研究描述40个模型。
  • 最常用预测因子为基线美国国立卫生研究院卒中量表(NIHSS;n=35)、年龄(n=22)和血糖水平(n=22)。
  • 在MR CLEAN注册研究中,sICH发生于188/3180(5.9%)患者。
  • 区分度范围从0.51(SPAN-100)到0.61(SITS-SICH和STARTING-SICH)。
  • 校准最佳的模型为IST-3(截距,-0.15 [95% CI,-0.01至-0.31];斜率,0.80 [95% CI,0.50-1.09])、SITS-SICH(截距,0.15 [95% CI,-0.01至0.30];斜率,0.62 [95% CI,0.38-0.87])和STARTING-SICH(截距,-0.03 [95% CI,-0.19至0.12];斜率,0.56 [95% CI,0.35-0.76])。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Symptomatic intracranial hemorrhage (sICH) is a severe complication of reperfusion therapy for ischemic stroke. Multiple models have been developed to predict sICH or intracranial hemorrhage (ICH) after reperfusion therapy. We provide an overview of published models and validate their ability to predict sICH in patients treated with endovascular treatment in daily clinical practice. METHODS: We conducted a systematic search to identify models either developed or validated to predict sICH or ICH after reperfusion therapy (intravenous thrombolysis and/or endovascular treatment) for ischemic stroke. Models were externally validated in the MR CLEAN Registry (n=3180; Multicenter Randomized Clinical Trial of Endovascular Treatment for Acute Ischemic Stroke in the Netherlands). The primary outcome was sICH according to the Heidelberg Bleeding Classification. Model performance was evaluated with discrimination (c-statistic, ideally 1; a c-statistic below 0.7 is considered poor in discrimination) and calibration (slope, ideally 1, and intercept, ideally 0). RESULTS: We included 39 studies describing 40 models. The most frequently used predictors were baseline National Institutes of Health Stroke Scale (NIHSS; n=35), age (n=22), and glucose level (n=22). In the MR CLEAN Registry, sICH occurred in 188/3180 (5.9%) patients. Discrimination ranged from 0.51 (SPAN-100 [Stroke Prognostication Using Age and National Institutes of Health Stroke Scale]) to 0.61 (SITS-SICH [Safe Implementation of Treatments in Stroke Symptomatic Intracerebral Hemorrhage] and STARTING-SICH [STARTING Symptomatic Intracerebral Hemorrhage]). Best calibrated models were IST-3 (intercept, -0.15 [95% CI, -0.01 to -0.31]; slope, 0.80 [95% CI, 0.50-1.09]), SITS-SICH (intercept, 0.15 [95% CI, -0.01 to 0.30]; slope, 0.62 [95% CI, 0.38-0.87]), and STARTING-SICH (intercept, -0.03 [95% CI, -0.19 to 0.12]; slope, 0.56 [95% CI, 0.35-0.76]). CONCLUSIONS: The investigated models to predict sICH or ICH discriminate poorly between patients with a low and high risk of sICH after endovascular treatment in daily clinical practice and are, therefore, not clinically useful for this patient population.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. van der Ende NAM, Kremers FCC, van der Steen W, et al. Symptomatic Intracranial Hemorrhage After Endovascular Stroke Treatment: External Validation of Prediction Models. Stroke. 2023. PMID: 36689584. doi:10.1161/STROKEAHA.122.040065

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。